Calculators

401k Retirement Calculator Mortgage Calculator

New

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

FSMEX

Fidelity Select Portfolio Medical Technology and Devices Portfolio

FSMEX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FSMEX Analyst Rating

Moderate Buy

33 Buy

7 Hold

0 Sell

Based on the consensus analyst ratings on 40 stocks held in FSMEX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FSMEX Analyst Price Target

Average Price Target

$74.49

Based on 40 Wall Street analysts offering 12 month price targets to Fidelity Select Portfolio Medical Technology and Devices Portfolio holdings in the last 3 months. The average price target is $74.49 with a high forecast of $83.42 and a low forecast of $64.29. The average price target represents a 21.15% change from the last price of $61.48.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"50":"$50","67":"$67","84":"$84","58.5":"$58.5","75.5":"$75.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":83.424,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n  <span style=\"color:#199ca5\">$83.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":74.485,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n  <span style=\"color:#828080\">$74.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":64.293,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n  <span style=\"color:#912767\">$64.29</span>\n  </div></div>","useHTML":true}}],"tickPositions":[50,58.5,67,75.5,84],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Jan<br/>2024","9":"Apr<br/>2024","12":"Jul<br/>2024","25":"Jul<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.77,63.435692307692314,65.10138461538462,66.76707692307693,68.43276923076924,70.09846153846155,71.76415384615385,73.42984615384616,75.09553846153847,76.76123076923078,78.42692307692309,80.09261538461539,81.7583076923077,{"y":83.424,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.77,62.74807692307692,63.72615384615385,64.70423076923078,65.68230769230769,66.66038461538461,67.63846153846154,68.61653846153847,69.59461538461538,70.57269230769231,71.55076923076923,72.52884615384616,73.50692307692307,{"y":74.485,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.77,61.964076923076924,62.15815384615385,62.35223076923077,62.5463076923077,62.74038461538462,62.93446153846154,63.12853846153847,63.32261538461539,63.51669230769231,63.71076923076924,63.90484615384616,64.09892307692309,{"y":64.293,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":64.68,"date":1688342400000,"info":"<div>Price: <b>$65<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":64.64,"date":1690848000000,"info":"<div>Price: <b>$65<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":62.46,"date":1693526400000,"info":"<div>Price: <b>$62<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":56.67,"date":1696204800000,"info":"<div>Price: <b>$57<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":51.69,"date":1698796800000,"info":"<div>Price: <b>$52<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":57.51,"date":1701388800000,"info":"<div>Price: <b>$58<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.76,"date":1704153600000,"info":"<div>Price: <b>$62<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":64.54,"date":1706745600000,"info":"<div>Price: <b>$65<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":66.58,"date":1709251200000,"info":"<div>Price: <b>$67<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":66.81,"date":1711929600000,"info":"<div>Price: <b>$67<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.29,"date":1714521600000,"info":"<div>Price: <b>$63<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":62.8,"date":1717372800000,"info":"<div>Price: <b>$63<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":61.77,"date":1719792000000,"info":"<div>Price: <b>$62<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$83.42

Average Price Target$74.49

Lowest Price Target$64.29

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FSMEX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EVH

Evolent Health Inc.

―

8 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TXG

10X Genomics

―

6 Buy

6 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ATRC

Atricure, Inc.

―

9 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

INSP

Inspire Medical

―

9 Buy

6 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DIM

Sartorius Stedim Biotech

―

5 Buy

3 Hold

0 Sell

Moderate Buy

―

FSMEX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GKOS

Glaukos Corp.

―

9 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SWAV

Shockwave Medical

―

2 Buy

8 Hold

0 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ISRG

Intuitive Surgical

―

14 Buy

5 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Edwards Lifesciences Corp.

―

15 Buy

7 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BSX

Boston Scientific

―

21 Buy

1 Hold

0 Sell

Strong Buy

―

FSMEX Mutual Fund FAQ

What is FSMEX’s average 12-month price target, according to analysts?

Based on analyst ratings, Fidelity Select Portfolio Medical Technology and Devices Portfolio’s 12-month average price target is $74.49.

What is FSMEX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FSMEX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FSMEX a Buy, Sell or Hold?

Fidelity Select Portfolio Medical Technology and Devices Portfolio has a consensus rating of Moderate Buy which is based on 33 buy ratings, 7 hold ratings and 0 sell ratings.

What is Fidelity Select Portfolio Medical Technology and Devices Portfolio’s price target?

The average price target for Fidelity Select Portfolio Medical Technology and Devices Portfolio is $74.49. This is based on 40 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $83.42 ,the lowest forecast is $64.29. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Fidelity Select Portfolio Medical Technology and Devices Portfolio?

Fidelity Select Portfolio Medical Technology and Devices Portfolio’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 40 Wall Streets Analysts.

How can I buy shares of FSMEX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing